1. Home
  2. TNFA vs EDBL Comparison

TNFA vs EDBL Comparison

Compare TNFA & EDBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNFA
  • EDBL
  • Stock Information
  • Founded
  • TNFA 2014
  • EDBL 2020
  • Country
  • TNFA United States
  • EDBL United States
  • Employees
  • TNFA N/A
  • EDBL N/A
  • Industry
  • TNFA
  • EDBL Farming/Seeds/Milling
  • Sector
  • TNFA
  • EDBL Consumer Staples
  • Exchange
  • TNFA NYSE
  • EDBL Nasdaq
  • Market Cap
  • TNFA 3.7M
  • EDBL 4.1M
  • IPO Year
  • TNFA N/A
  • EDBL 2022
  • Fundamental
  • Price
  • TNFA $1.20
  • EDBL $0.15
  • Analyst Decision
  • TNFA
  • EDBL
  • Analyst Count
  • TNFA 0
  • EDBL 0
  • Target Price
  • TNFA N/A
  • EDBL N/A
  • AVG Volume (30 Days)
  • TNFA 27.7K
  • EDBL 12.1M
  • Earning Date
  • TNFA 11-29-2024
  • EDBL 11-13-2024
  • Dividend Yield
  • TNFA N/A
  • EDBL N/A
  • EPS Growth
  • TNFA N/A
  • EDBL N/A
  • EPS
  • TNFA N/A
  • EDBL N/A
  • Revenue
  • TNFA N/A
  • EDBL $14,069,000.00
  • Revenue This Year
  • TNFA N/A
  • EDBL $14.19
  • Revenue Next Year
  • TNFA N/A
  • EDBL $27.76
  • P/E Ratio
  • TNFA N/A
  • EDBL N/A
  • Revenue Growth
  • TNFA N/A
  • EDBL 7.88
  • 52 Week Low
  • TNFA $1.15
  • EDBL $0.12
  • 52 Week High
  • TNFA $10.68
  • EDBL $13.00
  • Technical
  • Relative Strength Index (RSI)
  • TNFA 36.11
  • EDBL 27.98
  • Support Level
  • TNFA $1.26
  • EDBL $0.14
  • Resistance Level
  • TNFA $1.44
  • EDBL $0.19
  • Average True Range (ATR)
  • TNFA 0.13
  • EDBL 0.02
  • MACD
  • TNFA -0.02
  • EDBL 0.02
  • Stochastic Oscillator
  • TNFA 7.69
  • EDBL 32.26

About TNFA TNF PHARMACEUTICALS INC EFFEC

TNF Pharmaceuticals Inc is a clinical-stage pharmaceutical company committed to extending a healthy lifespan. The company is developing and commercializing two therapeutic platforms. MyMD-1 is a small molecule that regulates the immunometabolic system to treat autoimmune diseases, including multiple sclerosis, diabetes, rheumatoid arthritis, and inflammatory bowel disease. It is being developed to treat age-related illnesses such as frailty and sarcopenia. Supera-CBD is a synthetic derivative of CBD being developed to treat various conditions, including epilepsy, pain, and anxiety/depression, through its effects on the CB2 receptor, opioid receptors, and monoamine oxidase enzyme type B.

About EDBL Edible Garden AG Incorporated

Edible Garden AG Inc is a next-generation controlled environment agriculture farming company. It uses traditional agricultural growing techniques together with technology to grow fresh, organic food, sustainably and safely while improving traceability. The company uses the controlled environment of traditional greenhouse structures, such as glass greenhouses, together with hydroponic and vertical greenhouses to sustainably grow organic herbs and lettuces.

Share on Social Networks: